Balance Sheet
Cash Flow Statement
Daily Values
DMA 100DMA 200DMA 50Dividend YieldEV to CFOEV to EBITEV to EBITDAEV to FCFEnterprise ValueMarket Cap to FCFMarket CapitalizationPricePrice to Earnings
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Incannex Healthcare (IXHL) Enterprise Value (2020 - 2025)

Incannex Healthcare's Enterprise Value history spans 4 years, with the latest figure at -$69.2 million for Q4 2025.

  • On a quarterly basis, Enterprise Value fell 3198.38% to -$69.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$69.2 million, a 3198.38% decrease, with the full-year FY2025 number at -$15.0 million, down 156.73% from a year prior.
  • Enterprise Value hit -$69.2 million in Q4 2025 for Incannex Healthcare, up from -$73.3 million in the prior quarter.
  • Over the last five years, Enterprise Value for IXHL hit a ceiling of -$2.1 million in Q4 2024 and a floor of -$73.3 million in Q3 2025.
  • Historically, Enterprise Value has averaged -$22.2 million across 3 years, with a median of -$11.9 million in 2023.
  • Biggest five-year swings in Enterprise Value: skyrocketed 85.58% in 2024 and later crashed 3198.38% in 2025.
  • Tracing IXHL's Enterprise Value over 3 years: stood at -$14.6 million in 2023, then skyrocketed by 85.58% to -$2.1 million in 2024, then crashed by 3198.38% to -$69.2 million in 2025.
  • Business Quant data shows Enterprise Value for IXHL at -$69.2 million in Q4 2025, -$73.3 million in Q3 2025, and -$15.0 million in Q2 2025.